Royalty Pharma PLCNASDAQ:RPRX
- LAST PRICE28.2800
- TODAY'S CHANGE (%)-0.2100 (-0.7371%)
- Bid / Lots28.1300/ 1
- Ask / Lots28.5800/ 1
- Open / Previous Close28.5000 / 28.4900
- Day Range
- 52 Week Range
- Volume2,949,021
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPRX |
|---|---|---|
| 09:32 ET | 13816 | 28.515 |
| 09:34 ET | 5499 | 28.57 |
| 09:36 ET | 4003 | 28.5 |
| 09:38 ET | 30852 | 28.44 |
| 09:39 ET | 30000 | 28.425 |
| 09:41 ET | 4322 | 28.52 |
| 09:43 ET | 16441 | 28.35 |
| 09:45 ET | 6522 | 28.43 |
| 09:48 ET | 5896 | 28.44 |
| 09:50 ET | 4555 | 28.42 |
| 09:52 ET | 16995 | 28.45 |
| 09:54 ET | 8051 | 28.42 |
| 09:56 ET | 6613 | 28.46 |
| 09:57 ET | 4816 | 28.42 |
| 09:59 ET | 14927 | 28.43 |
| 10:01 ET | 7769 | 28.4 |
| 10:03 ET | 10401 | 28.385 |
| 10:06 ET | 3630 | 28.4 |
| 10:08 ET | 5871 | 28.385 |
| 10:10 ET | 4149 | 28.39 |
| 10:12 ET | 107754 | 28.48 |
| 10:14 ET | 4900 | 28.45 |
| 10:15 ET | 3982 | 28.415 |
| 10:17 ET | 2150 | 28.37 |
| 10:19 ET | 48482 | 28.355 |
| 10:21 ET | 2536 | 28.375 |
| 10:24 ET | 8959 | 28.39 |
| 10:26 ET | 7744 | 28.405 |
| 10:28 ET | 2884 | 28.39 |
| 10:30 ET | 24357 | 28.3688 |
| 10:32 ET | 3629 | 28.35 |
| 10:33 ET | 3499 | 28.32 |
| 10:35 ET | 3426 | 28.355 |
| 10:37 ET | 900 | 28.355 |
| 10:39 ET | 1956 | 28.345 |
| 10:42 ET | 5628 | 28.35 |
| 10:44 ET | 3601 | 28.325 |
| 10:46 ET | 2103 | 28.309 |
| 10:48 ET | 1572 | 28.3 |
| 10:50 ET | 17488 | 28.315 |
| 10:51 ET | 3679 | 28.355 |
| 10:53 ET | 1100 | 28.355 |
| 10:55 ET | 3471 | 28.36 |
| 10:57 ET | 6484 | 28.35 |
| 11:00 ET | 8732 | 28.375 |
| 11:02 ET | 1564 | 28.3686 |
| 11:04 ET | 7968 | 28.36 |
| 11:06 ET | 4612 | 28.33 |
| 11:08 ET | 1948 | 28.31 |
| 11:09 ET | 2750 | 28.31 |
| 11:11 ET | 3277 | 28.3175 |
| 11:13 ET | 4317 | 28.325 |
| 11:15 ET | 6053 | 28.31 |
| 11:18 ET | 2359 | 28.305 |
| 11:20 ET | 9444 | 28.29 |
| 11:22 ET | 3322 | 28.33 |
| 11:24 ET | 3719 | 28.315 |
| 11:26 ET | 31349 | 28.325 |
| 11:27 ET | 7518 | 28.35 |
| 11:29 ET | 4024 | 28.36 |
| 11:31 ET | 1486 | 28.395 |
| 11:33 ET | 1525 | 28.375 |
| 11:36 ET | 1000 | 28.365 |
| 11:38 ET | 1000 | 28.355 |
| 11:40 ET | 13402 | 28.32 |
| 11:42 ET | 21435 | 28.316 |
| 11:44 ET | 11635 | 28.28 |
| 11:45 ET | 13846 | 28.295 |
| 11:47 ET | 7455 | 28.305 |
| 11:49 ET | 2500 | 28.31 |
| 11:51 ET | 9242 | 28.325 |
| 11:54 ET | 6393 | 28.3 |
| 11:56 ET | 3035 | 28.315 |
| 11:58 ET | 3109 | 28.295 |
| 12:00 ET | 3837 | 28.295 |
| 12:02 ET | 3953 | 28.26 |
| 12:03 ET | 19237 | 28.225 |
| 12:05 ET | 16233 | 28.26 |
| 12:07 ET | 7947 | 28.265 |
| 12:09 ET | 4956 | 28.255 |
| 12:12 ET | 6034 | 28.26 |
| 12:14 ET | 3100 | 28.26 |
| 12:16 ET | 1231 | 28.255 |
| 12:18 ET | 7726 | 28.26 |
| 12:20 ET | 1626 | 28.2701 |
| 12:21 ET | 1200 | 28.26 |
| 12:23 ET | 1516 | 28.26 |
| 12:25 ET | 1304 | 28.24 |
| 12:27 ET | 3555 | 28.24 |
| 12:30 ET | 1835 | 28.2399 |
| 12:32 ET | 1722 | 28.245 |
| 12:34 ET | 1643 | 28.26 |
| 12:36 ET | 200 | 28.255 |
| 12:38 ET | 800 | 28.25 |
| 12:39 ET | 1300 | 28.24 |
| 12:41 ET | 804 | 28.2305 |
| 12:43 ET | 7225 | 28.24 |
| 12:45 ET | 3281 | 28.22 |
| 12:48 ET | 1263 | 28.23 |
| 12:50 ET | 4576 | 28.2199 |
| 12:52 ET | 6014 | 28.2092 |
| 12:54 ET | 4267 | 28.219 |
| 12:56 ET | 1656 | 28.22 |
| 12:57 ET | 2300 | 28.21 |
| 12:59 ET | 1565 | 28.2 |
| 01:01 ET | 2877 | 28.205 |
| 01:03 ET | 3100 | 28.18 |
| 01:06 ET | 3850 | 28.17 |
| 01:08 ET | 951 | 28.17 |
| 01:10 ET | 3176 | 28.175 |
| 01:12 ET | 5162 | 28.18 |
| 01:14 ET | 1121 | 28.185 |
| 01:15 ET | 4759 | 28.195 |
| 01:17 ET | 1394 | 28.205 |
| 01:19 ET | 2933 | 28.205 |
| 01:21 ET | 1500 | 28.2 |
| 01:24 ET | 2335 | 28.195 |
| 01:26 ET | 801 | 28.19 |
| 01:28 ET | 2923 | 28.18 |
| 01:30 ET | 8234 | 28.2 |
| 01:32 ET | 31152 | 28.2 |
| 01:33 ET | 3575 | 28.185 |
| 01:35 ET | 2633 | 28.175 |
| 01:37 ET | 536 | 28.175 |
| 01:39 ET | 8473 | 28.165 |
| 01:42 ET | 4905 | 28.19 |
| 01:44 ET | 1300 | 28.18 |
| 01:46 ET | 5517 | 28.155 |
| 01:48 ET | 4516 | 28.165 |
| 01:50 ET | 2705 | 28.16 |
| 01:51 ET | 4573 | 28.19 |
| 01:53 ET | 15274 | 28.145 |
| 01:55 ET | 4952 | 28.14 |
| 01:57 ET | 5342 | 28.14 |
| 02:00 ET | 1107 | 28.145 |
| 02:02 ET | 3907 | 28.125 |
| 02:04 ET | 2922 | 28.12 |
| 02:06 ET | 4314 | 28.135 |
| 02:08 ET | 4768 | 28.125 |
| 02:09 ET | 21859 | 28.125 |
| 02:11 ET | 2380 | 28.135 |
| 02:13 ET | 2424 | 28.145 |
| 02:15 ET | 1255 | 28.15 |
| 02:18 ET | 1579 | 28.13 |
| 02:20 ET | 1128 | 28.12 |
| 02:22 ET | 3494 | 28.12 |
| 02:24 ET | 1113 | 28.12 |
| 02:26 ET | 1500 | 28.105 |
| 02:27 ET | 2546 | 28.115 |
| 02:29 ET | 1306 | 28.115 |
| 02:31 ET | 4995 | 28.125 |
| 02:33 ET | 1770 | 28.13 |
| 02:36 ET | 2667 | 28.14 |
| 02:38 ET | 747 | 28.135 |
| 02:40 ET | 3088 | 28.14 |
| 02:42 ET | 2148 | 28.145 |
| 02:44 ET | 3593 | 28.15 |
| 02:45 ET | 7642 | 28.15 |
| 02:47 ET | 6075 | 28.15 |
| 02:49 ET | 6564 | 28.15 |
| 02:51 ET | 1266 | 28.15 |
| 02:54 ET | 5472 | 28.135 |
| 02:56 ET | 5617 | 28.13 |
| 02:58 ET | 6383 | 28.145 |
| 03:00 ET | 2313 | 28.15 |
| 03:02 ET | 10657 | 28.14 |
| 03:03 ET | 5786 | 28.14 |
| 03:05 ET | 3225 | 28.14 |
| 03:07 ET | 4797 | 28.155 |
| 03:09 ET | 848 | 28.1575 |
| 03:12 ET | 889 | 28.16 |
| 03:14 ET | 6932 | 28.185 |
| 03:16 ET | 4168 | 28.18 |
| 03:18 ET | 8748 | 28.16 |
| 03:20 ET | 1292 | 28.16 |
| 03:21 ET | 1942 | 28.165 |
| 03:23 ET | 6255 | 28.175 |
| 03:25 ET | 5359 | 28.1687 |
| 03:27 ET | 2519 | 28.15 |
| 03:30 ET | 8605 | 28.175 |
| 03:32 ET | 16561 | 28.19 |
| 03:34 ET | 11713 | 28.22 |
| 03:36 ET | 6756 | 28.22 |
| 03:38 ET | 2142 | 28.225 |
| 03:39 ET | 5315 | 28.22 |
| 03:41 ET | 8853 | 28.23 |
| 03:43 ET | 7656 | 28.21 |
| 03:45 ET | 17929 | 28.23 |
| 03:48 ET | 13310 | 28.23 |
| 03:50 ET | 15264 | 28.25 |
| 03:52 ET | 79990 | 28.25 |
| 03:54 ET | 40739 | 28.3 |
| 03:56 ET | 26315 | 28.275 |
| 03:57 ET | 59097 | 28.27 |
| 03:59 ET | 486831 | 28.28 |
Apr 19, 2024
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024, from 8:15AM ET on Friday Apr 19, 2024 by Dow Jones
8:15AM ET on Friday Apr 19, 2024 by Dow Jones
Apr 17, 2024
Royalty Pharma Declares Second Quarter 2024 Dividend, from 8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:15AM ET on Wednesday Apr 17, 2024 by Dow JonesPress Release: Royalty Pharma Declares Second Quarter 2024 Dividend, from 8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
Apr 12, 2024
DJ Royalty Pharma Is Maintained at Buy by B of A Securities, from 8:11AM ET on Friday Apr 12, 2024 by Dow Jones
8:11AM ET on Friday Apr 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Royalty Pharma PLC | 17.0B | 11.2x | +1.83% |
Amneal Pharmaceuticals Inc | 2.1B | -11.5x | --- |
Catalent Inc | 10.2B | -7.9x | --- |
Jazz Pharmaceuticals PLC | 6.9B | 22.9x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Roivant Sciences Ltd | 9.3B | 2.2x | --- |
Company Information
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Contact Information
- Headquarters
- 110 East 59th StreetNEW YORK, NY, United States 10022
- Phone
- 212-883-0200
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pablo Legorreta
- Vice Chairman, Executive Vice President
- Christopher Hite
- Chief Financial Officer, Executive Vice President
- Terrance Coyne
- Executive Vice President - Investments and Chief Legal Officer
- George Lloyd
- Executive Vice President - Research and Investments
- Marshall Urist
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $17.0B |
|---|---|
Revenue (TTM) | $2.4B |
Shares Outstanding | 597.4M |
Dividend Yield | 2.97% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.48 |
EPS | $2.54 |
Book Value | $14.61 |
P/E Ratio | 11.2x |
Price/Sales (TTM) | 7.2 |
Price/Cash Flow (TTM) | 10.0x |
Operating Margin | 63.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
